New drug cocktails aim to shrink Hard-to-Treat breast tumors
Disease control
Terminated
This study tested several drug combinations in 24 people with metastatic triple-negative breast cancer, a type that has spread and is hard to treat. The drugs work by blocking cancer growth signals or boosting the immune system. The study was stopped early, so results are limited…
Phase: PHASE2 • Sponsor: Gordon Mills, MD, PhD • Aim: Disease control
Last updated May 15, 2026 11:53 UTC